ATR · Aptargroup, Inc. · Financials

$146.17 -0.70 (-0.47%) Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$9.31B

63.39M

Volume · Nov 5 124.94K Avg daily vol (3M) 466.07K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$3.78B +5.4%

FY2025

Net Income

$392.79M +4.9%

FY2025

Gross Margin

30.93% +0.4pp

FY2020

Operating Margin

13.26% -0.6pp

FY2025

Diluted EPS

$5.89 +6.5%

FY2025

Operating Cash Flow

$570M -11.4%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	+4.4%	+5.2%	+5.0%	$3.99B	$3.78B	$3.58B	$3.49B	$3.32B	$3.23B	$2.93B	$2.86B	$2.76B	$2.47B	$2.33B	$2.32B	$2.6B	$2.52B	$2.35B	$2.36B	$2.09B	$1.86B	$2.07B
Gross Profit	—	—	—	—	—	—	—	—	—	$906.01M	$874.39M	$795.51M	$723.46M	$687.38M	$679.85M	$695.65M	$666.15M	$606.83M	$636.85M	$568.54M	—	—
Gross Margin	—	—	—	—	—	—	—	—	—	30.93%	30.58%	28.77%	29.3%	29.49%	29.34%	26.78%	26.43%	25.86%	27.03%	27.2%	—	—
Research & Development	+4.0%	+2.6%	+4.6%	—	$105.1M	$96.1M	$92.8M	$93.5M	$99.8M	$92.5M	$82.8M	$75.3M	$68.2M	$66.2M	$67.1M	$76.2M	$71.8M	$65.4M	$67M	$51.4M	$50.2M	—
Amortization of Intangibles	+1.1%	+2.5%	+26.6%	$44.55M	$45.05M	$44.12M	$44.72M	$43.57M	$41.07M	$39.79M	$27.61M	$15.46M	$10.34M	$9.32M	$4.25M	$5.33M	$5.03M	$3.18M	$2.2M	$3.62M	—	—
Depreciation & Amortization	+7.1%	+5.5%	+7.5%	$307.49M	$287.36M	$263.78M	$248.59M	$233.71M	$234.85M	$220.3M	$194.55M	$171.75M	$153.09M	$154.8M	$138.89M	$152.22M	$149.96M	$137.02M	$134.24M	$132.96M	$133.01M	$131.15M
Restructuring Charges	+14.2%	-18.0%	—	$8.76M	$9.84M	$13M	$45M	$6.6M	$23.24M	$26.49M	$20.47M	$63.83M	$2.21M	—	—	—	$11.8M	$3.1M	-$71K	$93K	$7.56M	—
Total Costs & Expenses	+3.6%	+4.8%	+5.1%	$3.52B	$3.28B	$3.09B	$3.08B	$2.94B	$2.88B	$2.59B	$2.49B	$2.48B	$2.15B	$2.02B	$1.99B	$2.29B	$2.24B	$2.07B	$2.05B	$1.81B	$1.64B	$1.84B
Operating Income	+9.7%	+8.1%	+4.5%	$475.5M	$501.04M	$496.5M	$404.02M	$379.27M	$347.35M	$339.5M	$371.69M	$286.27M	$323.49M	$313.69M	$324.15M	$306.42M	$284.57M	$258.91M	$287.1M	$268.01M	$198.38M	$234.17M
Operating Margin	—	—	—	—	13.26%	13.86%	11.58%	11.42%	10.76%	11.59%	13%	10.35%	13.1%	13.46%	13.99%	11.8%	11.29%	11.03%	12.18%	12.82%	10.69%	11.3%
EBITDA	+8.8%	+7.1%	+5.5%	$782.99M	$788.4M	$760.28M	$652.61M	$612.98M	$582.2M	$559.8M	$566.25M	$458.02M	$476.58M	$468.49M	$463.04M	$458.63M	$434.53M	$395.94M	$421.34M	$400.97M	$331.39M	$365.32M
Interest Expense	+8.9%	+9.7%	+4.3%	$65.74M	$52.74M	$43.9M	$40.42M	$40.83M	$30.28M	$33.24M	$35.49M	$32.63M	$40.6M	$35.24M	$34.62M	$21.03M	$20.51M	$18.95M	$17.3M	$14.37M	$16.49M	$18.69M
Interest Income	+62.9%	+64.9%	+7.6%	$12.94M	$11.68M	$12.1M	$4.37M	$2.7M	$3.67M	$958K	$4.17M	$7.06M	$5.47M	$2.64M	$5.6M	$4.8M	$3.23M	$3M	$5.72M	$3.25M	$3.33M	$13.12M
Other Non-Operating Income	—	—	—	-$6M	-$2.03M	$3.27M	$3.21M	-$4.8M	-$3.09M	-$7.68M	$1.56M	$5.55M	$6.69M	-$407K	$163K	-$1.97M	-$2.03M	-$1.13M	-$559K	-$2.52M	-$1.34M	-$2.19M
Equity in Earnings of Unconsolidated Entities	+151.1%	—	—	$4.48M	$7.39M	$87K	$2.23M	$467K	-$692K	-$1.44M	$135K	-$229K	-$229K	-$191K	-$718K	-$1.92M	-$883K	-$457K	-$17K	$15K	$164K	$310K
Investment Income (Loss)	—	—	—	-$2.49M	-$483K	$1.71M	$1.41M	-$2.11M	$4.71M	$3.06M	$0	—	—	—	—	—	—	—	—	—	—	—
Pretax Income	+13.7%	+10.3%	+5.3%	$360.67M	$491.38M	$469.77M	$374.83M	$334.7M	$321.66M	$301.16M	$342.07M	$266.02M	$294.83M	$280.5M	$294.57M	$286.3M	$264.38M	$241.37M	$274.94M	$254.39M	$184.06M	—
Income Tax	+1.3%	+2.6%	+0.4%	$92.8M	$98.88M	$95.59M	$90.65M	$95.15M	$78.02M	$87.07M	$99.84M	$71.25M	$74.8M	$74.89M	$95.28M	$94.68M	$92.46M	$78.95M	$91.31M	$80.8M	$59.46M	$73.23M
Net Income	+18.0%	+12.9%	+7.0%	$267.19M	$392.79M	$374.54M	$284.49M	$239.29M	$244.1M	$214.04M	$242.23M	$194.77M	$220.03M	$205.6M	$199.3M	$191.62M	$171.93M	$162.42M	$183.63M	$173.48M	$124.62M	$153.5M
Net Margin	—	—	—	—	10.4%	10.45%	8.16%	7.2%	7.56%	7.31%	8.47%	7.04%	8.91%	8.82%	8.6%	7.38%	6.82%	6.92%	7.79%	8.3%	6.72%	7.41%
Net Income Attributable to Noncontrolling Interests	—	—	—	—	—	-$363K	-$311K	$267K	-$459K	$50K	$25K	$21K	-$1000	$14K	-$53K	-$34K	-$68K	-$192K	-$53K	$108K	-$26K	$6000
Net Income Available to Common Stockholders	+18.0%	+12.9%	+7.0%	$267.19M	$392.79M	$374.54M	$284.49M	$239.29M	$244.1M	$214.04M	$242.2M	$194.75M	$220.03M	$205.59M	$199.35M	$191.66M	$171.99M	$162.61M	$183.68M	$173.48M	$124.62M	—
Comprehensive Income	+43.8%	+18.3%	+29.7%	$269.11M	$635.89M	$254.04M	$316.89M	$213.96M	$209.77M	$274.28M	$210.76M	$144.2M	$286.44M	$148.23M	$47.05M	-$28.14M	$221.06M	$162.98M	$120.24M	$111.15M	—	—
EPS (Basic) USD/shares	+17.7%	+12.5%	+6.5%	$4.16	$5.97	$5.65	$4.34	$3.66	$3.72	$3.32	$3.81	$3.12	$3.52	$3.27	$3.19	$2.95	$2.60	$2.45	$2.76	$2.58	$1.84	$2.26
EPS (Diluted) USD/shares	+17.9%	+12.9%	+6.7%	$4.12	$5.89	$5.53	$4.25	$3.59	$3.61	$3.21	$3.66	$3.00	$3.41	$3.17	$3.09	$2.85	$2.52	$2.38	$2.65	$2.48	$1.79	$2.18
Shares Outstanding (Basic Avg) shares	+0.2%	+0.4%	+0.5%	—	65.74M	66.33M	65.62M	65.4M	65.66M	64.42M	63.57M	62.44M	62.44M	62.8M	62.59M	65.01M	66.09M	66.39M	66.55M	67.34M	67.64M	—
Shares Outstanding (Diluted Avg) shares	0.0%	0.0%	+0.3%	—	66.73M	67.69M	66.91M	66.72M	67.68M	66.66M	66.15M	64.96M	64.6M	64.85M	64.49M	67.29M	68.21M	68.4M	69.27M	69.82M	69.79M	—

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.68B in buybacks, $1.4B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Finance lease liabilities	2026-09-30	USD 22,444,000	10-Q filed 2026-10-30
Long-term debt and lease obligations, including current maturities	2026-09-30	USD 1,145,976,000	10-Q filed 2026-10-30
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current long-term debt and lease obligations USD 121,241,000 Noncurrent long-term debt and lease obligations USD 1,024,735,000
Noncurrent operating lease liabilities	2026-09-30	USD 42,940,000	10-Q filed 2026-10-30
Short-term borrowings	2026-09-30	USD 229,440,000	10-Q filed 2026-10-30

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

2.62×

Peer median 2.92×

EV/EBIT

22.02×

Peer median 31.30×

P/E (TTM)

35.65×

Peer median 32.90×

Price/Sales (TTM)

2.33×

Peer median 2.82×

Price/Book

3.56×

Peer median 2.92×

Peer medians compare against the 24 similar-size Medical Instruments & Supplies companies (of 51 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Pharma Segment	$1,738,470,000	$1,644,012,000	$1,520,993,000	—	—	—	—	—
Beauty Segment	$1,338,138,000	$1,252,904,000	$1,297,477,000	—	—	—	—	—
Closures Segment	$736,943,000	$721,564,000	$706,847,000	—	—	—	—	—
Aptar Beauty	—	$1,252,904,000	$1,297,477,000	$1,246,018,000	$1,204,312,000	—	—	—
Aptar Closures	—	$721,564,000	$706,847,000	$748,055,000	$768,497,000	—	—	—
Aptar Pharma	—	$1,644,012,000	$1,521,837,000	$1,372,449,000	$1,297,996,000	—	—	—
Beauty and Home	—	—	—	$1,461,894,000	$1,456,208,000	$1,320,988,000	$1,352,714,000	$1,426,382,000
Food Beverage	—	—	—	$523,643,000	$511,112,000	$407,435,000	$415,967,000	$383,727,000
Pharma	—	—	—	$1,372,449,000	$1,297,996,000	$1,234,107,000	$1,091,051,000	$954,652,000
Food And Beverage	—	—	—	—	—	—	$418,017,000	$386,689,000

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
United States	$1,071,430,000	$1,037,968,000	$949,248,000	$972,920,000	—	—	—	—
Other Europe	$788,065,000	$748,302,000	$727,662,000	$665,537,000	$170,521,000	$152,376,000	$149,083,000	$146,701,000
Other Foreign Countries	$648,786,000	$619,552,000	$586,451,000	$555,298,000	—	—	—	—
France	$513,281,000	$499,795,000	$541,333,000	$487,650,000	$906,057,000	$854,639,000	$895,110,000	$862,364,000
Italy	$201,895,000	$180,101,000	$200,817,000	$149,725,000	$161,676,000	$148,636,000	$141,867,000	$144,044,000
Spain	$195,405,000	$171,779,000	$175,101,000	$149,987,000	—	—	—	—
China	$194,406,000	$155,502,000	$146,026,000	$177,855,000	—	—	—	—
Germany	$163,913,000	$169,891,000	$160,812,000	$163,277,000	$486,928,000	$448,405,000	$452,409,000	$474,369,000
Asia	—	—	—	—	$204,173,000	$165,255,000	$164,107,000	$175,328,000
Latin America	—	—	—	—	$216,043,000	$194,043,000	$220,388,000	$235,619,000
North America	—	—	—	—	$1,081,823,000	$965,986,000	$836,768,000	$726,336,000

Key facts CIK 896622 CUSIP 038336103 13F (30d) 238 filings 209 filers Visit website Investor relations